Prime Manager Luxon shows corporate style in NZ top job Prime Minister Chris Luxon's managerial persona - including plans, KPIs and corporate-babble - is setting the tone for his New Zealand government. AAP · Feb 16, 2024
Caladrius Biosciences To Merge With Privately-Held Cend Therapeutics Caladrius Biosciences Inc (NASDAQ:CLBS) and privately-held Cend Therapeutics Inc have agreed to merge in an all-stock approximate "merger of equals" transaction approved by the Boards of Directors of each company. The transaction values each company at $90 million, which for Caladrius represents a 136% premium to its market cap on April 26. Following closing, the… Benzinga · Apr 27, 2022